Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul;73(3):242-249.
doi: 10.1016/j.mjafi.2017.01.001. Epub 2017 Feb 16.

To study the efficacy of thallium-201 as tumor seeking agent and to study its role in therapeutic response

Affiliations

To study the efficacy of thallium-201 as tumor seeking agent and to study its role in therapeutic response

A V S Anil Kumar et al. Med J Armed Forces India. 2017 Jul.

Abstract

Background: Tumour seeking characteristics of TL-201 have been underutilized. The study was undertaken to evaluate the role of TL-201 scintigraphy in tumour imaging.

Methods: A total of 50 cases were studied over a period of 18 months (13 lymphomas, 11 breast carcinoma, 10 lung cancer, 6 of soft tissue sarcoma, 2 bone tumours and 4 cases each of thyroid and brain tumours). Thallium-201 chloride was injected IV in the dose range of 3-5 mCi. Imaging was done using Siemen's ECAM dual headed gamma camera. Mean tumour to background ratio (T/B ratio) was calculated for all the positive cases. Descriptive statistical analysis was carried out.

Results: Findings revealed a sensitivity of 94.12%, specificity 87.5%, PPV 94.12%, NPV 87.50% and accuracy of 92% for TL-201 tumour imaging. The mean T/B ratio for the true positive cases at 10 min and at 3 h was 1.81 and 1.99 respectively, the difference being 0.18 (P value <0.001). Amongst them, the mean T/B ratios for low-grade tumours were 1.45 ± 0.32 at 10 min and 1.63 ± 0.38 after 3 h with difference of 0.176 (P < 0.001). For the high-grade tumours the ratios were 2.08 ± 0.35 and 2.26 ± 0.41 respectively with a difference of 0.186 (P < 0.001).

Conclusion: Thallium-201 scintigraphy is a useful tumour imaging modality in cases of thyroid, breast, brain, lung, soft tissue and bone tumours and lymphomas. A T/B ratio of 1.63 ± 0.38 in 3 h-delayed imaging is suggestive of low-grade tumours. For high-grade tumours a ratio of 2.26 ± 0.41 should be considered significant.

Keywords: Scintigraphy; T/B ratio; Thallium.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Benign breast nodule right where the thallium scan is negative. There is no abnormal uptake seen in the right breast.
Fig. 2
Fig. 2
NSCLC right lung – false negative thallium scan. There is no abnormal uptake seen in the right lung.
Fig. 3
Fig. 3
Carcinoma right breast (operated). Thallium scan showing uptake in the outer quadrant of right breast with T/B ratio of 2.5. Relapse was confirmed by biopsy.
Fig. 4
Fig. 4
Glioblastoma multiforme (operated). Scan shows abnormal uptake in the left parietal region with an early T/B ratio of 1.6 and late ratio of 2.5.
Fig. 5
Fig. 5
NSCLC left lung post surgery and post chemotherapy. Thallium scan shows uptake in the left lower lobe with an early T/B ratio of 2.3 and late T/B ratio of 2.5.
Fig. 6
Fig. 6
Astrocytoma right frontal region. Scan reveals no abnormal focus of uptake.
Fig. 7
Fig. 7
Thallium scan shows hot focus in the amputation stump with a T/B ratio of 1.2. The histopathology revealed only granulation tissue.
Fig. 8
Fig. 8
Low-grade carcinoma right breast. Thallium scan showing low uptake.
Fig. 9
Fig. 9
High-grade carcinoma right breast. Thallium scan showing high uptake.

Similar articles

Cited by

References

    1. Gehring P.J., Hammand P.B. The interrelationship between thallium and potassium in animals. J Pharmacol Exp Ther. 1967;155:187–201. - PubMed
    1. Lebowitz E., Greene M.W., Fairchild R. Thallium-201 for medical use. I. J Nucl Med. 1975;16:151–155. - PubMed
    1. Waxman A.D. Nuclear Medicine Annual. Raven Press; New York: 1991. Thallium-201 in nuclear oncology; pp. 193–209.
    1. Elgazzer A.H., Fernandez-Ulloa M., Silberstein E.B. 201-T1 as a tumour-localizing agent: current status and future considerations. Nucl Med Commun. 1993;14:96–103. - PubMed
    1. Nadel H.R. Thallium-201 for oncological imaging in children. Semin Nucl Med. 1993;23:243–254. - PubMed

LinkOut - more resources